ArticleChannels (Austin, Tex.)2022

Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers.

Thomas W Comollo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.